Surgery

New acrylic implant provides option for patients with endothelial dysfunction.

A web app-based personalized music intervention before cataract surgery may lower anxiety levels or reduce the need for sedative medication.

Proposal hints at the use of generative adversarial network (GAN) for applications in macular surgery

“Real talk” on new devices gives surgeons, patients decision-making insights

Ophthalmologist outlines his journey with the procedure as a late adopter.

Procedure transfers intact donor nerve fibers to the cornea.

Staying current on phaco technology can help surgeons provide better outcomes.

Sustained-release option is deposited directly into the lenticular capsule.

According to investigators, the risk of death from strokes, heart attacks and other vascular causes is increased by more than a third.

Three cases demonstrate value of new tools, technology for surgeons.

Techniques, technologies minimize complications and guide counseling, care.

Factors that lead to complications must be managed for best outcomes.

Researchers consider frequency and factors in etiology of complication

Lens an option for complicated eyes, astigmatism, monovision candidates.

The company will host Innovation Week from Sept. 21-23, demonstrating new data management innovations across devices, workflow solutions and software applications.

Investigators examine usefulness in refractive surgery evaluations.

Pilot study shows promise of teaching surgeons with technology.

Speed the return to baseline visual acuity—and make your patients happy.

CXL is safe, effective to perform on younger population, study results show.

OD-OS’s teleguidance offering addresses the lack of experts and also benefits teaching in retina laser care.

Early experience with next-generation lens engenders positive perception.

Single-use cataract surgery comes with several safety and quality attributes.

Steven Greenstein, MD, reports on the 10-year postop data from an epi-off corneal collagen cross-linking treatment in keratoconus and ectasia patients.

Sight Sciences reveals real-world data that show the safety, efficacy, and durability of effect of its Omni Surgical System for use in a standalone procedure to reduce IOP and medication burden.

Understanding nuances of reimbursement for novel, sustained-release ophthalmic drugs can help maximize the opportunity for patients and practice.